-
Publication Venue For
-
Interpreting the Benefit of Simvastatin-Ezetimibe in Patients 75 Years or Older-Reply.
2020
-
Questioning the Benefit of Statins for Low-Risk Populations-Medical Misinformation or Scientific Evidence?-Reply.
2019
-
Initiation of Angiotensin-Neprilysin Inhibition After Acute Decompensated Heart Failure: Secondary Analysis of the Open-label Extension of the PIONEER-HF Trial.
2019
-
Clinical Considerations Prior to Transition From Triple Antithrombotic Therapy to Dual Antithrombotic Therapy-Reply.
2019
-
Age-Related Differences in the Noninvasive Evaluation for Possible Coronary Artery Disease: Insights From the Prospective Multicenter Imaging Study for Evaluation of Chest Pain (PROMISE) Trial.
2019
-
Contemporary Patterns of Medicare and Medicaid Utilization and Associated Spending on Sacubitril/Valsartan and Ivabradine in Heart Failure.
2019
-
Does Guideline-Directed Medical Therapy for Heart Failure Offer Benefits After LVAD Placement?-A Call for a Randomized Clinical Trial.
2019
-
Effects of a 9-Week Hybrid Comprehensive Telerehabilitation Program on Long-term Outcomes in Patients With Heart Failure: The Telerehabilitation in Heart Failure Patients (TELEREH-HF) Randomized Clinical Trial.
2019
-
Patient Perceptions and Familiarity With Medical Therapy for Heart Failure.
2019
-
Association of a P2Y12 Inhibitor Copayment Reduction Intervention With Persistence and Adherence With Other Secondary Prevention Medications: A Post Hoc Analysis of the ARTEMIS Cluster-Randomized Clinical Trial.
2019
-
Logistical Challenges Associated With Implementing Precision Medicine-Reply.
2019
-
Apolipoprotein B Particles and Cardiovascular Disease: A Narrative Review.
2019
-
Postoperative and Nonvalvular Atrial Fibrillation-Not So Different After All.
2019
-
Current Demographic Status of Cardiologists in the United States.
2019
-
Proposed Framework for the Optimal Measurement of Quality Assessment in Percutaneous Coronary Intervention.
2019
-
Cost-effectiveness of Low-density Lipoprotein Cholesterol Level-Guided Statin Treatment in Patients With Borderline Cardiovascular Risk.
2019
-
Myocardial Injury in the Era of High-Sensitivity Cardiac Troponin Assays: A Practical Approach for Clinicians.
2019
-
Demographics, Care Patterns, and Outcomes of Patients Admitted to Cardiac Intensive Care Units: The Critical Care Cardiology Trials Network Prospective North American Multicenter Registry of Cardiac Critical Illness.
2019
-
Regional Differences in Secondary Prevention Therapy-Geography Should Not Be Destiny.
2019
-
Comparison of Major Adverse Cardiac Events Between Instantaneous Wave-Free Ratio and Fractional Flow Reserve-Guided Strategy in Patients With or Without Type 2 Diabetes: A Secondary Analysis of a Randomized Clinical Trial.
2019
-
Effect of Simvastatin-Ezetimibe Compared With Simvastatin Monotherapy After Acute Coronary Syndrome Among Patients 75 Years or Older: A Secondary Analysis of a Randomized Clinical Trial.
2019
-
Impediments to Implementing Guideline-Directed Medical Therapies.
2019
-
Association Between Warfarin Control Metrics and Atrial Fibrillation Outcomes in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation.
2019
-
Association of Coronary Anatomical Complexity With Clinical Outcomes After Percutaneous or Surgical Revascularization in the Veterans Affairs Clinical Assessment Reporting and Tracking Program.
2019
-
Fear-Based Medical Misinformation and Disease Prevention: From Vaccines to Statins.
2019
-
Safety and Efficacy of Antithrombotic Strategies in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Network Meta-analysis of Randomized Controlled Trials.
2019
-
Effect of a Multifaceted Quality Improvement Intervention on the Prescription of Evidence-Based Treatment in Patients at High Cardiovascular Risk in Brazil: The BRIDGE Cardiovascular Prevention Cluster Randomized Clinical Trial..
4:408-417.
2019
-
Effect of a Quality of Care Improvement Initiative in Patients With Acute Coronary Syndrome in Resource-Constrained Hospitals in China: A Randomized Clinical Trial..
4:418-427.
2019
-
Electronic Health Record Data Quality Issues Are Not Remedied by Increasing Granularity of Diagnosis Codes..
4:465.
2019
-
Misclassification of Myocardial Injury as Myocardial Infarction: Implications for Assessing Outcomes in Value-Based Programs..
4:460-464.
2019
-
Quantifying the Treatment Effect of Drug-Eluting Stents Optimized for Biocompatibility vs Bare-Metal Stents With a Single Month of Dual Antiplatelet Therapy-Reply..
4:494-495.
2019
-
Trends in Readmissions and Length of Stay for Patients Hospitalized With Heart Failure in Canada and the United States..
4:444-453.
2019
-
Evaluation of Mortality Data From the Social Security Administration Death Master File for Clinical Research..
4:375-379.
2019
-
Baseline Characteristics and Risk Profiles of Participants in the ISCHEMIA Randomized Clinical Trial..
4:273-286.
2019
-
Prognostic Value of Vasodilator Stress Cardiac Magnetic Resonance Imaging: A Multicenter Study With 48 000 Patient-Years of Follow-up..
4:256-264.
2019
-
Statins Work, but Only in People Who Take Them..
4:214.
2019
-
What Is Needed Now to Improve Cardiovascular Clinical Registries in the Future..
4:201-202.
2019
-
Association of Physician Variation in Use of Manual Aspiration Thrombectomy With Outcomes Following Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction: The National Cardiovascular Data Registry CathPCI Registry..
4:110-118.
2019
-
Improving Value-Based Care for Left Ventricular Assist Device Therapy: Lowering Costs When Stakes Are High..
4:161-162.
2019
-
Association of Cardiac Injury and Malignant Left Ventricular Hypertrophy With Risk of Heart Failure in African Americans: The Jackson Heart Study..
4:51-58.
2019
-
Incidence, Characteristics, and Outcomes of Myocardial Infarction in Patients With Peripheral Artery Disease: Insights From the EUCLID Trial..
4:7-15.
2019
-
Association of Race/Ethnicity With Oral Anticoagulant Use in Patients With Atrial Fibrillation: Findings From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II..
3:1174-1182.
2018
-
Association of Transcatheter Mitral Valve Repair With Quality of Life Outcomes at 30 Days and 1 Year: Analysis of the Transcatheter Valve Therapy Registry..
3:1151-1159.
2018
-
Electrocardiography Screening for Atrial Fibrillation: We Can Do Better..
3:1144-1145.
2018
-
Errors in Programming and Coding Affecting Cohorts Included in the Study Deriving and Validating the PROMISE Minimal-Risk Tool..
3:1253-1254.
2018
-
Influence of Cardiovascular Risk Communication Tools and Presentation Formats on Patient Perceptions and Preferences..
3:1192-1199.
2018
-
Moving the Needle Toward a More Personalized Means of Patient Care..
3:1146-1148.
2018
-
Role Models, Allies, and Diversity-Global Issues for Female Cardiology Trainees-Reply..
3:1252.
2018
-
A Long-term Benefit Approach vs Standard Risk-Based Approaches for Statin Eligibility in Primary Prevention..
3:1090-1095.
2018
-
Association of Same-Day Discharge After Elective Percutaneous Coronary Intervention in the United States With Costs and Outcomes..
3:1041-1049.
2018
-
Efficacy and Safety of Drug-Eluting Stents Optimized for Biocompatibility vs Bare-Metal Stents With a Single Month of Dual Antiplatelet Therapy: A Meta-analysis..
3:1050-1059.
2018
-
Timing of Loading Dose of Atorvastatin in Patients Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndromes: Insights From the SECURE-PCI Randomized Clinical Trial..
3:1113-1118.
2018
-
Association of Variants in BAG3 With Cardiomyopathy Outcomes in African American Individuals..
3:929-938.
2018
-
Enrollment of Older Patients, Women, and Racial and Ethnic Minorities in Contemporary Heart Failure Clinical Trials: A Systematic Review..
3:1011-1019.
2018
-
Tools for Evaluating and Improving Causal Inference: Introducing JAMA Cardiology Readers to the Risk of Bias in Nonrandomized Studies of Interventions (ROBINS-I) Tool..
3:907.
2018
-
Trends in Hospice Discharge and Relative Outcomes Among Medicare Patients in the Get With The Guidelines-Heart Failure Registry..
3:917-926.
2018
-
Association of Interleukin 6 Receptor Variant With Cardiovascular Disease Effects of Interleukin 6 Receptor Blocking Therapy: A Phenome-Wide Association Study..
3:849-857.
2018
-
Finding Means to Fulfill the Societal and Academic Imperative for Open Data Access and Sharing..
3:793-794.
2018
-
Association of Patient Perceptions of Cardiovascular Risk and Beliefs on Statin Drugs With Racial Differences in Statin Use: Insights From the Patient and Provider Assessment of Lipid Management Registry..
3:739-748.
2018
-
Career Preferences and Perceptions of Cardiology Among US Internal Medicine Trainees: Factors Influencing Cardiology Career Choice..
3:682-691.
2018
-
Management of Ventricular Arrhythmias and Sudden Cardiac Death Risk Associated With Cardiac Channelopathies..
3:775-776.
2018
-
Association of Cardiovascular Outcomes With Masked Hypertension Defined by Home Blood Pressure Monitoring in a Japanese General Practice Population..
3:583-590.
2018
-
Evolution of Left Ventricular Assist Device Therapy for Advanced Heart Failure: A Review..
3:650-658.
2018
-
Left Ventricular Thrombus After Acute Myocardial Infarction: Screening, Prevention, and Treatment..
3:642-649.
2018
-
When Low-Risk Atrial Fibrillation Is Not So Low Risk: Beast of Burden..
3:558-560.
2018
-
Association of Hospital Performance Based on 30-Day Risk-Standardized Mortality Rate With Long-term Survival After Heart Failure Hospitalization: An Analysis of the Get With The Guidelines-Heart Failure Registry..
3:489-497.
2018
-
Management of Ventricular Arrhythmias and Sudden Cardiac Death Risk Related to Ischemic and Nonischemic Cardiomyopathy..
3:541-542.
2018
-
Long-term Thromboembolic Risk in Patients With Postoperative Atrial Fibrillation After Coronary Artery Bypass Graft Surgery and Patients With Nonvalvular Atrial Fibrillation..
3:417-424.
2018
-
Mass Customization, Ubiquitous Information, and Improvements to Health Outcomes in the United States..
3:365-366.
2018
-
The Burden of Cardiovascular Diseases Among US States, 1990-2016..
3:375-389.
2018
-
Ticagrelor vs Clopidogrel After Fibrinolytic Therapy in Patients With ST-Elevation Myocardial Infarction: A Randomized Clinical Trial..
3:391-399.
2018
-
Association of Cardiovascular Biomarkers With Incident Heart Failure With Preserved and Reduced Ejection Fraction..
3:215-224.
2018
-
Direct Oral Anticoagulants in Addition to Antiplatelet Therapy for Secondary Prevention After Acute Coronary Syndromes: A Systematic Review and Meta-analysis..
3:234-241.
2018
-
Outpatient Worsening Heart Failure as a Target for Therapy: A Review..
3:252-259.
2018
-
Coronary Calcium Score and Cardiovascular Risk in Elderly Populations-Reply..
3:180-181.
2018
-
Efficacy of High-Sensitivity Troponin T in Identifying Very-Low-Risk Patients With Possible Acute Coronary Syndrome..
3:104-111.
2018
-
Use of High-Risk Coronary Atherosclerotic Plaque Detection for Risk Stratification of Patients With Stable Chest Pain: A Secondary Analysis of the PROMISE Randomized Clinical Trial..
3:144-152.
2018
-
Association of of Atrial Fibrillation Clinical Phenotypes With Treatment Patterns and Outcomes: A Multicenter Registry Study..
3:54-63.
2018
-
Association of the Hospital Readmissions Reduction Program Implementation With Readmission and Mortality Outcomes in Heart Failure..
3:44-53.
2018
-
Association of Physical Activity With Risk of Major Cardiovascular Diseases in Chinese Men and Women..
2:1349-1358.
2017
-
Administrative Codes for Capturing In-Hospital Cardiac Arrest..
2:1275-1277.
2017
-
Association of Prior Authorization and Out-of-pocket Costs With Patient Access to PCSK9 Inhibitor Therapy..
2:1217-1225.
2017
-
Association of Public Health Initiatives With Outcomes for Out-of-Hospital Cardiac Arrest at Home and in Public Locations..
2:1226-1235.
2017
-
Implantable Cardioverter Defibrillators for Nonischemic Cardiomyopathy-Reply..
2:1283-1284.
2017
-
Longitudinal Hemodynamics of Transcatheter and Surgical Aortic Valves in the PARTNER Trial..
2:1197-1206.
2017
-
The Benefit Model for Prevention of Cardiovascular Disease: An Opportunity to Harmonize Guidelines..
2:1175-1176.
2017
-
When Should Patients Be Involved in Cardiovascular Clinical Trial Design?: Always, Early, and Often..
2:1269-1270.
2017
-
Association of Neighborhood Demographics With Out-of-Hospital Cardiac Arrest Treatment and Outcomes: Where You Live May Matter..
2:1110-1118.
2017
-
Incentivizing Transradial Access for Primary Percutaneous Coronary Intervention While Maintaining Timely Reperfusion..
2:1057-1058.
2017
-
Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor Therapy-Breakthrough in Low-Density Lipoprotein Cholesterol Lowering, Breakdown in Value..
2:1066-1068.
2017
-
SPECT, PET, and CTA-Acronyms or Better Imaging?.
2:1108-1109.
2017
-
Association of Coronary Artery Calcium Score vs Age With Cardiovascular Risk in Older Adults: An Analysis of Pooled Population-Based Studies..
2:986-994.
2017
-
Comparative Outcomes After Percutaneous Coronary Intervention Among Black and White Patients Treated at US Veterans Affairs Hospitals..
2:967-975.
2017
-
Efficacy and Safety of Spironolactone in Acute Heart Failure: The ATHENA-HF Randomized Clinical Trial..
2:950-958.
2017
-
Myocardial Fibrosis in Duchenne and Becker Muscular Dystrophy-Reply..
2:1046.
2017
-
Use of Prescription Smoking Cessation Medications After Myocardial Infarction Among Older Patients in Community Practice..
2:1040-1042.
2017
-
Outcomes Associated With Subcutaneous Implantable Cardioverter Defibrillators-Reply..
2:925-926.
2017
-
Sildenafil Treatment in Heart Failure With Preserved Ejection Fraction: Targeted Metabolomic Profiling in the RELAX Trial..
2:896-901.
2017
-
Trends and Outcomes of Off-label Use of Transcatheter Aortic Valve Replacement: Insights From the NCDR STS/ACC TVT Registry..
2:846-854.
2017
-
Accuracy of Medical Claims for Identifying Cardiovascular and Bleeding Events After Myocardial Infarction : A Secondary Analysis of the TRANSLATE-ACS Study..
2:750-757.
2017
-
Association of US Centers for Medicare and Medicaid Services Hospital 30-Day Risk-Standardized Readmission Metric With Care Quality and Outcomes After Acute Myocardial Infarction: Findings From the National Cardiovascular Data Registry/Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With the Guidelines..
2:723-731.
2017
-
Efficacy of Flecainide in the Treatment of Catecholaminergic Polymorphic Ventricular Tachycardia: A Randomized Clinical Trial..
2:759-766.
2017
-
Coronary Artery Calcification and Risk of Cardiovascular Disease and Death Among Patients With Chronic Kidney Disease..
2:635-643.
2017
-
Heterogeneity in Blood Pressure Transitions Over the Life Course: Age-Specific Emergence of Racial/Ethnic and Sex Disparities in the United States..
2:653-661.
2017
-
Integrating Research With Clinical Practice: Keeping It Simple..
2:616.
2017
-
Primary Prevention Implantable Cardioverter Defibrillators in Patients With Nonischemic Cardiomyopathy: A Meta-analysis..
2:685-688.
2017
-
Subclinical Atherosclerosis, Statin Eligibility, and Outcomes in African American Individuals: The Jackson Heart Study..
2:644-652.
2017
-
Economic Analysis of Apixaban Therapy for Patients With Atrial Fibrillation From a US Perspective: Results From the ARISTOTLE Randomized Clinical Trial..
2:525-534.
2017
-
Heart Failure With Reduced Ejection Fraction in Human Immunodeficiency Virus Infection: The More Things Stay the Same..
2:476-477.
2017
-
Long-term Safety and Efficacy of Achieving Very Low Levels of Low-Density Lipoprotein Cholesterol : A Prespecified Analysis of the IMPROVE-IT Trial..
2:547-555.
2017
-
Mortality Following Cardiovascular and Bleeding Events Occurring Beyond 1 Year After Coronary Stenting: A Secondary Analysis of the Dual Antiplatelet Therapy (DAPT) Study..
2:478-487.
2017
-
Value of Cardiovascular Magnetic Resonance Imaging-Derived Baseline Left Ventricular Ejection Fraction and Volumes for Precise Risk Stratification of Patients With Ischemic Cardiomyopathy: Insights From the Surgical Treatment for Ischemic Heart Failure (STICH) Trial..
2:577-579.
2017
-
Assessing the Utility of Transcatheter Aortic Valve Replacement..
2:416-417.
2017
-
Identification of Patients With Stable Chest Pain Deriving Minimal Value From Noninvasive Testing: The PROMISE Minimal-Risk Tool, A Secondary Analysis of a Randomized Clinical Trial..
2:400-408.
2017
-
Quality-of-Life Outcomes After Transcatheter Aortic Valve Replacement in an Unselected Population: A Report From the STS/ACC Transcatheter Valve Therapy Registry..
2:409-416.
2017
-
Racial Differences in Associations of Blood Pressure Components in Young Adulthood With Incident Cardiovascular Disease by Middle Age: Coronary Artery Risk Development in Young Adults (CARDIA) Study..
2:381-389.
2017
-
Statin Eligibility Under American and European Cholesterol Guidelines-Reply..
2:460.
2017
-
The Complexities of Hypertension: One Disease or Many?.
2:389-390.
2017
-
Evaluation of Structural Progression in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy..
2:293-302.
2017
-
Ongoing Management of Patients With Supraventricular Tachycardia..
2:332-333.
2017
-
Quality of Evidence Underlying the American Heart Association/American College of Cardiology/Heart Rhythm Society Guidelines on the Management of Atrial Fibrillation..
2:319-323.
2017
-
The Role of Cardiovascular Implantable Electronic Devices in the Detection and Treatment of Subclinical Atrial Fibrillation: A Review..
2:324-331.
2017
-
Factors Associated With and Prognostic Implications of Cardiac Troponin Elevation in Decompensated Heart Failure With Preserved Ejection Fraction: Findings From the American Heart Association Get With The Guidelines-Heart Failure Program..
2:136-145.
2017
-
Myocardial Fibrosis Progression in Duchenne and Becker Muscular Dystrophy: A Randomized Clinical Trial..
2:190-199.
2017
-
Prediction of 30-Day All-Cause Readmissions in Patients Hospitalized for Heart Failure: Comparison of Machine Learning and Other Statistical Approaches..
2:204-209.
2017
-
Resting Heart Rate and Long-term Outcomes Among the African American Population: Insights From the Jackson Heart Study..
2:172-180.
2017
-
Differences in Clinical and Functional Outcomes of Atrial Fibrillation in Women and Men-Reply..
2:108-110.
2017
-
Intensive Care Unit Utilization and Mortality Among Medicare Patients Hospitalized With Non-ST-Segment Elevation Myocardial Infarction..
2:36-44.
2017
-
Making Every Mobile Heart Count!.
2:78.
2017
-
Who Belongs in the Cardiac Intensive Care Unit?.
2:45-46.
2017
-
Do Not Over (P) Value Your Research Article..
1:1055.
2016
-
Risk Prediction With Electronic Health Records: The Importance of Model Validation and Clinical Context..
1:976-977.
2016
-
Same-Day Discharge After Percutaneous Coronary Intervention-Reply..
1:1080.
2016
-
Understanding the Role of P Values and Hypothesis Tests in Clinical Research..
1:1048-1054.
2016
-
Assessing Cardiovascular Risk to Guide Hypertension Diagnosis and Treatment..
1:864-871.
2016
-
Outcomes in the Randomized CoreValve US Pivotal High Risk Trial in Patients With a Society of Thoracic Surgeons Risk Score of 7% or Less..
1:945-949.
2016
-
The US Food and Drug Administration and the Future of Cardiovascular Medicine..
1:950-952.
2016
-
Trends and In-Hospital Outcomes Associated With Adoption of the Subcutaneous Implantable Cardioverter Defibrillator in the United States..
1:900-911.
2016
-
The Need to Improve Care and Research on Sexual Functioning in Cardiology..
1:765-766.
2016
-
Treatment, Outcomes, and Adherence to Medication Regimens Among Dual Medicare-Medicaid-Eligible Adults With Myocardial Infarction..
1:787-794.
2016
-
Apixaban 5 mg Twice Daily and Clinical Outcomes in Patients With Atrial Fibrillation and Advanced Age, Low Body Weight, or High Creatinine: A Secondary Analysis of a Randomized Clinical Trial..
1:673-681.
2016
-
Comparing Inverse Probability of Treatment Weighting and Instrumental Variable Methods for the Evaluation of Adenosine Diphosphate Receptor Inhibitors After Percutaneous Coronary Intervention..
1:655-665.
2016
-
Population Effect of Differences in Cholesterol Guidelines in Eastern Europe and the United States..
1:700-707.
2016
-
Potential Mortality Reduction With Optimal Implementation of Angiotensin Receptor Neprilysin Inhibitor Therapy in Heart Failure..
1:714-717.
2016
-
Association of Fibroblast Growth Factor 23 With Atrial Fibrillation in Chronic Kidney Disease, From the Chronic Renal Insufficiency Cohort Study..
1:548-556.
2016
-
Biomarkers to Predict Risk in Apparently Well Populations..
1:528-529.
2016
-
Evaluation of Flow After Transcatheter Aortic Valve Replacement in Patients With Low-Flow Aortic Stenosis: A Secondary Analysis of the PARTNER Randomized Clinical Trial..
1:584-592.
2016
-
Trends in Palliative Care Use in Veterans With Severe Heart Failure Using a Large National Cohort..
1:617-619.
2016
-
Acute Treatment of Patients With Supraventricular Tachycardia..
1:483-485.
2016
-
Efficacy and Safety of Apixaban Compared With Warfarin in Patients With Atrial Fibrillation in Relation to Renal Function Over Time: Insights From the ARISTOTLE Randomized Clinical Trial..
1:451-460.
2016
-
Genetic Investigation Into the Differential Risk of Atrial Fibrillation Among Black and White Individuals..
1:442-450.
2016
-
Risk of Premature Cardiovascular Disease vs the Number of Premature Cardiovascular Events..
1:492-494.
2016
-
Understanding the Adverse Effects of Ticagrelor in Practice..
1.
2016
-
Differences in Clinical and Functional Outcomes of Atrial Fibrillation in Women and Men: Two-Year Results From the ORBIT-AF Registry..
1:282-291.
2016
-
Gait Speed and Operative Mortality in Older Adults Following Cardiac Surgery..
1:314-321.
2016
-
Association Between Sitagliptin Use and Heart Failure Hospitalization and Related Outcomes in Type 2 Diabetes Mellitus: Secondary Analysis of a Randomized Clinical Trial..
1:126-135.
2016
-
Effect of the Presence and Type of Angina on Cardiovascular Events in Patients Without Known Coronary Artery Disease Referred for Elective Coronary Angiography..
1:232-234.
2016
-
Same-Day Discharge After Percutaneous Coronary Intervention: Current Perspectives and Strategies for Implementation..
1:216-223.
2016
-
The Enigma of Glucose and Lipid Metabolism..
1:145-146.
2016
-
Timing of First Postdischarge Follow-up and Medication Adherence After Acute Myocardial Infarction..
1:147-155.
2016
-
Using Data to Guide Anticoagulation in Patients With Atrial Fibrillation: Does the Analysis Fit the Question?.
1:121-122.
2016
-
Association Between Hospital Process Composite Performance and Patient Outcomes After In-Hospital Cardiac Arrest Care..
1:37-45.
2016
-
Development and Validation of Risk Prediction Models for Cardiovascular Events in Black Adults: The Jackson Heart Study Cohort..
1:15-25.
2016
-
Development and Validation of a Risk Prediction Model for In-Hospital Mortality After Transcatheter Aortic Valve Replacement..
1:46-52.
2016
-
Preventing Stroke in Patients With Atrial Fibrillation-A Steep Climb Away From Achieving Peak Performance..
1:63-64.
2016
-
Sudden Cardiac Death After Non-ST-Segment Elevation Acute Coronary Syndrome..
1:73-79.
2016
-
P2Y12 Inhibitor Switching in Response to Routine Notification of CYP2C19 Clopidogrel Metabolizer Status Following Acute Coronary Syndromes.
2019